Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin nasal spray vs placebo in adults with autism
IRCT20200404046938N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in Autism Spectrum Disorder (ASD) comparing Oxytocin nasal spray with Placebo nasal spray (2 arms). Started Mar 2022; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT20200404046938N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200404046938N1.